Skip to main content

Peer Review reports

From: Cost-utility analysis of palonosetron in the antiemetic regimen for cisplatin-containing highly emetogenic chemotherapy in Japan

Original Submission
19 Feb 2019 Submitted Original manuscript
21 May 2019 Author responded Author comments - Munenobu Kashiwa
5 Apr 2019 Reviewed Reviewer Report - Umberto Restelli
20 Apr 2019 Reviewed Reviewer Report - Smitha Saldanha
21 Apr 2019 Reviewed Reviewer Report - Bo Yu
Resubmission - Version 2
21 May 2019 Submitted Manuscript version 2
6 Jun 2019 Reviewed Reviewer Report - Umberto Restelli
16 Jun 2019 Reviewed Reviewer Report - Smitha Saldanha
17 Jun 2019 Reviewed Reviewer Report - Bo Yu
Resubmission - Version 3
Submitted Manuscript version 3
Publishing
19 Jun 2019 Editorially accepted
1 Jul 2019 Article published 10.1186/s12913-019-4281-0

You can find further information about peer review here.

Back to article page
\